Xenon Pharmaceuticals (XENE) Short Interest Ratio & Short Volume $31.34 -0.14 (-0.45%) As of 02:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xenon Pharmaceuticals Short Interest DataXenon Pharmaceuticals (XENE) has a short interest of 92,400 shares, representing 5.92% of the float (the number of shares available for trading by the public). This marks a -97.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 636,580 shares to cover all short positions.Current Short Interest92,400 sharesPrevious Short Interest3,690,000 sharesChange Vs. Previous Month-97.50%Dollar Volume Sold Short$2.89 millionShort Interest Ratio0.7 Days to CoverLast Record DateJune 30, 2025Outstanding Shares76,734,000 sharesFloat Size1,560,000 sharesShort Percent of Float5.92%Today's Trading Volume314,870 sharesAverage Trading Volume636,580 sharesToday's Volume Vs. Average49% Short Selling Xenon Pharmaceuticals? Sign up to receive the latest short interest report for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXENE Short Interest Over TimeXENE Days to Cover Over TimeXENE Percentage of Float Shorted Over Time Xenon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202592,400 shares $2.89 million -97.5%5.9%0.7 $31.30 6/15/20253,690,000 shares $120.88 million +9.5%5.1%3.6 $32.76 5/31/20253,370,000 shares $96.79 million -2.9%4.7%3.5 $28.72 5/15/20253,470,000 shares $102.61 million -3.1%4.8%3.9 $29.57 4/30/20253,580,000 shares $136.76 million -9.8%N/A5.1 $38.20 4/15/20253,970,000 shares $131.13 million +0.5%5.5%6.5 $33.03 3/31/20253,950,000 shares $132.52 million +8.5%5.5%7.3 $33.55 3/15/20253,640,000 shares $128.56 million -3.2%5.1%8.1 $35.32 2/28/20253,760,000 shares $139.20 million -4.1%5.2%8.4 $37.02 2/15/20253,920,000 shares $152.53 million +11.4%5.4%9.7 $38.91 Get the Latest News and Ratings for XENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20253,520,000 shares $140.73 million -2.0%N/A8.5 $39.98 1/15/20253,590,000 shares $144.07 million +3.2%N/A9.1 $40.13 12/31/20243,480,000 shares $136.42 million +20.4%N/A8.9 $39.20 12/15/20242,890,000 shares $115.74 million +0.4%N/A7.5 $40.05 11/30/20242,880,000 shares $122.77 million -2.0%N/A7.8 $42.63 11/15/20242,940,000 shares $117.10 million +1.7%N/A8.2 $39.83 10/31/20242,890,000 shares $118.81 million -8.5%N/A8.5 $41.11 10/15/20243,160,000 shares $128.64 million -4.2%N/A9.2 $40.71 9/30/20243,300,000 shares $129.92 million -8.3%N/A8.9 $39.37 9/15/20243,600,000 shares $147.02 million +0.8%N/A9.2 $40.84 8/31/20243,570,000 shares $144.01 million +6.9%N/A9 $40.34 8/15/20243,340,000 shares $127.76 million +7.7%N/A7.9 $38.25 7/31/20243,100,000 shares $133.70 million -5.2%N/A7.4 $43.13 7/15/20243,270,000 shares $137.01 million +7.2%N/A7.9 $41.90 6/30/20243,050,000 shares $118.92 million -0.3%N/A7.8 $38.99 6/15/20243,060,300 shares $114.00 million +2.4%N/A8.4 $37.25 5/31/20242,990,000 shares $113.83 million +6.0%N/A8.7 $38.07 5/15/20242,820,000 shares $114.07 million +1.1%N/A8 $40.45 4/30/20242,790,000 shares $113.41 million +6.5%N/A7.8 $40.65 4/15/20242,620,000 shares $108.23 million -5.1%N/A7.3 $41.31 3/31/20242,760,000 shares $118.82 million +5.3%N/A7 $43.05 3/15/20242,620,000 shares $115.18 million -3.0%N/A5.7 $43.96 2/29/20242,700,000 shares $127.44 million +6.7%N/A5.3 $47.20 2/15/20242,530,000 shares $123.19 million -10.0%N/A4.2 $48.69 1/31/20242,810,000 shares $127.07 million +12.0%N/A4.2 $45.22 1/15/20242,510,000 shares $113.18 million +13.1%N/A3.6 $45.09 12/31/20232,220,000 shares $102.25 million -5.9%N/A3.3 $46.06 12/15/20232,360,000 shares $97.73 million +20.4%N/A3.6 $41.41 11/30/20231,960,000 shares $71.70 million +14.6%N/A3.3 $36.58 11/15/20231,710,000 shares $49.85 million -2.8%N/A3.4 $29.153..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 10/31/20231,760,000 shares $54.56 million -10.2%N/A4.2 $31.00 10/15/20231,960,000 shares $68.87 million -26.3%N/A5.2 $35.14 9/30/20232,660,000 shares $90.87 million -4.0%N/A7.2 $34.16 9/15/20232,770,000 shares $102.10 million -0.4%N/A8.6 $36.86 8/31/20232,780,000 shares $108.36 million +2.2%N/A8.5 $38.98 8/15/20232,720,000 shares $101.62 million +2.6%N/A7.8 $37.36 7/31/20232,650,000 shares $97.84 million -4.3%N/A7.8 $36.92 7/15/20232,770,000 shares $107.61 million -10.9%N/A7.7 $38.85 6/30/20233,110,000 shares $119.74 million -2.8%N/A8.6 $38.50 6/15/20233,200,000 shares $134.50 million +9.6%N/A8.3 $42.03 5/31/20232,920,000 shares $112.51 million -3.6%N/A7.5 $38.53 5/15/20233,030,000 shares $126.47 million -12.2%N/A7.5 $41.74 4/30/20233,450,000 shares $138.97 million -1.2%N/A8.5 $40.28 4/15/20233,490,000 shares $124.24 million -11.4%N/A9 $35.60 3/31/20233,940,000 shares $141.01 million +7.7%N/A9.8 $35.79 3/15/20233,660,000 shares $124.37 million +16.2%N/A9.3 $33.98 2/28/20233,150,000 shares $124.30 million +2.9%N/A8.1 $39.46 2/15/20233,060,000 shares $118.76 million +1.0%N/A8.3 $38.81 1/31/20233,030,000 shares $118.44 million -16.5%N/A8 $39.09 1/15/20233,630,000 shares $131.41 million +1.4%N/A9.5 $36.20 12/30/20223,580,000 shares $141.16 million -6.3%N/A9.6 $39.43 12/15/20223,820,000 shares $145.81 million +2.4%N/A10.4 $38.17 11/30/20223,730,000 shares $137.56 million +1.4%N/A10.7 $36.88 11/15/20223,680,000 shares $128.03 million +4.8%N/A10.3 $34.79 10/31/20223,510,000 shares $128.36 million +9.0%N/A9 $36.57 10/15/20223,220,000 shares $111.64 million +15.8%N/A8.2 $34.67 9/30/20222,780,000 shares $100.36 million +7.3%N/A6.9 $36.10 9/15/20222,590,000 shares $101.79 million +9.8%N/A5.9 $39.30 8/31/20222,360,000 shares $91.59 million +28.3%N/A4.6 $38.81 8/15/20221,840,000 shares $69.13 million -17.5%N/A3.5 $37.57 7/31/20222,230,000 shares $73.92 million -5.9%N/A4.2 $33.15 7/15/20222,370,000 shares $76.29 million +6.8%N/A4.5 $32.19 6/30/20222,220,000 shares $67.53 million -7.9%N/A4.1 $30.42 6/15/20222,410,000 shares $69.43 million -2.0%N/A4.3 $28.81 5/31/20222,460,000 shares $64.82 million -6.1%N/A5.2 $26.35 5/15/20222,620,000 shares $78.02 million +30.4%N/A5.7 $29.78 4/30/20222,010,000 shares $56.82 million -6.5%N/A4.8 $28.27 4/15/20222,150,000 shares $72.61 million -0.9%N/A5.2 $33.77 3/31/20222,170,000 shares $66.34 million -4.4%N/A4.6 $30.57 3/15/20222,270,000 shares $63.72 million +0.4%N/A5.6 $28.07 2/28/20222,260,000 shares $71.64 million +3.2%N/A5.4 $31.70 2/15/20222,190,000 shares $71.81 million +5.3%N/A4.9 $32.79 1/31/20222,080,000 shares $56.41 million +11.8%N/A4.3 $27.12 1/15/20221,860,000 shares $59.45 million +5.1%N/A3.6 $31.96 12/31/20211,770,000 shares $55.29 million -16.5%N/A3.1 $31.24 12/15/20212,120,000 shares $56.33 million +26.2%N/A1 $26.57 11/30/20211,680,000 shares $44.86 million -7.2%N/A0.8 $26.70 11/15/20211,810,000 shares $57.34 million +5.9%N/A0.9 $31.68 10/29/20211,710,000 shares $53.27 million -13.6%N/A0.8 $31.15 10/15/20211,980,000 shares $66.65 million +121.6%N/A1 $33.663..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/30/2021893,500 shares $13.65 million +52.4%N/A0.5 $15.28 9/15/2021586,400 shares $10.13 million +10.5%1.6%3.1 $17.28 8/31/2021530,600 shares $9.37 million -20.4%1.4%2.8 $17.65 8/13/2021666,500 shares $12.30 million -6.9%1.8%3.5 $18.45 7/30/2021715,700 shares $12.36 million -0.3%2.0%3.9 $17.27 7/15/2021717,700 shares $12.70 million +12.1%1.8%4.3 $17.69 6/30/2021640,500 shares $11.93 million +0.7%1.6%3.5 $18.62 6/15/2021636,100 shares $11.44 million -3.2%1.7%3.5 $17.99 5/28/2021657,400 shares $12.14 million -13.5%1.8%4.2 $18.47 5/14/2021759,600 shares $12.77 million -3.4%N/A3.9 $16.81 4/30/2021786,600 shares $14.40 million +0.5%N/A4.3 $18.31 4/15/2021782,900 shares $15.25 million +5.8%N/A3.8 $19.48 3/31/2021739,700 shares $12.94 million -13.8%N/A4 $17.49 3/15/2021858,200 shares $17.64 million -9.1%N/A4.2 $20.55 2/26/2021943,900 shares $17.10 million -3.4%N/A5.3 $18.12 2/12/2021977,100 shares $14.72 million -5.1%N/A5.9 $15.07 1/29/20211,030,000 shares $15.30 million -3.7%N/A6.4 $14.85 1/15/20211,070,000 shares $16.65 million -6.1%N/A6.8 $15.56 12/31/20201,140,000 shares $18.29 million +36.4%N/A8.1 $16.04 12/15/2020835,600 shares $10.11 million +0.8%N/A6.1 $12.10 11/30/2020829,400 shares $9.46 million +2.9%N/A7.6 $11.40 10/30/2020720,700 shares $6.93 million -45.0%N/A6.8 $9.62 10/15/20201,310,000 shares $14.63 million -4.4%N/A13.3 $11.17 9/30/20201,370,000 shares $15.17 million -0.7%N/A13.1 $11.07 9/15/20201,380,000 shares $15.18 million -0.7%N/A13.2 $11.00 8/31/20201,390,000 shares $16.89 million +14.9%N/A9.9 $12.15 8/14/20201,210,000 shares $13.09 million +7.1%N/A6.5 $10.82 7/31/20201,130,000 shares $12.35 million +9.7%N/A6.1 $10.93 XENE Short Interest - Frequently Asked Questions What is Xenon Pharmaceuticals' current short interest? Short interest is the volume of Xenon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 92,400 shares of XENE short. 5.92% of Xenon Pharmaceuticals' shares are currently sold short. Learn More on Xenon Pharmaceuticals' current short interest. What is a good short interest ratio for Xenon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XENE shares currently have a short interest ratio of 1.0. Learn More on Xenon Pharmaceuticals's short interest ratio. What is a good short interest percentage for Xenon Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.92% of Xenon Pharmaceuticals' floating shares are currently sold short. Is Xenon Pharmaceuticals' short interest increasing or decreasing? Xenon Pharmaceuticals saw a drop in short interest in June. As of June 30th, there was short interest totaling 92,400 shares, a drop of 97.5% from the previous total of 3,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xenon Pharmaceuticals' float size? Xenon Pharmaceuticals currently has issued a total of 76,734,000 shares. Some of Xenon Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xenon Pharmaceuticals currently has a public float of 1,560,000 shares. How does Xenon Pharmaceuticals' short interest compare to its competitors? 5.92% of Xenon Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Xenon Pharmaceuticals: BridgeBio Pharma, Inc. (14.05%), Verona Pharma PLC American Depositary Share (0.60%), Blueprint Medicines Corporation (5.95%), Roivant Sciences Ltd. (10.24%), Elanco Animal Health Incorporated (5.08%), Regencell Bioscience Holdings Limited (4.03%), Legend Biotech Corporation Sponsored ADR (5.68%), Revolution Medicines, Inc. (9.42%), Grifols, S.A. (1.00%), TG Therapeutics, Inc. (16.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Xenon Pharmaceuticals stock? Short selling XENE is an investing strategy that aims to generate trading profit from Xenon Pharmaceuticals as its price is falling. XENE shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenon Pharmaceuticals? A short squeeze for Xenon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XENE, which in turn drives the price of the stock up even further. How often is Xenon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XENE, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies BBIO Short Interest Data VRNA Short Interest Data BPMC Short Interest Data ROIV Short Interest Data ELAN Short Interest Data RGC Short Interest Data LEGN Short Interest Data RVMD Short Interest Data GRFS Short Interest Data TGTX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XENE) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XENE Stock Alerts